Skip to main content
. 2020 May 7;10(4):1095–1110. doi: 10.1007/s13346-020-00770-z

Table 4.

Self-emulsifying drug delivery system (SEDDS)–based antimalarial formulations

Drug Formulation ROA Comments Reference
Artemether Solid dispersions and self-emulsified solid dispersions Oral The solubility of artemether is enhanced. [47]
β-Artemether SMEDDS Oral The antimalarial activity was significantly enhanced (P < 0.05) as compared with the marketed formulation (Larither®). [48]
β-Artemether and lumefantrine SMEDDS Oral SMEDDS shows superior antimalarial activity with 100% survival as compared with the innovator (Coartem®) formulation. [49]
Artemether-lumefantrine Solid SMEDDS Oral Optimized SMEDDS formulation at a low, medium, and high doses found to be superior in terms of reduction in parasitemia as well as mortality in comparison with the marketed tablet of equivalent dose. [50]